NSC |
Compound |
Enrichment |
Correlation |
NSC 736761 |
16-[3-(2-morpholin-1-yl ethoxy)benzylidene]-5-androstene-3b,17b-diol diacetate |
0.0164116791870036 |
0.16780594 |
NSC 736818 |
Null |
0.0164116791870036 |
0.23201879 |
NSC 741237 |
Null |
0.0164116791870036 |
0.15773308 |
NSC 7521 |
[(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide |
0.0164116791870036 |
0.083299895 |
NSC 753188 |
4-chloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide |
0.0164116791870036 |
0.3072609 |
NSC 759877 |
Dasatinib (USAN) |
0.017138169515949 |
-0.15839604 |
NSC 709079 |
Null |
0.0171381695159494 |
0.33340181 |
NSC 727087 |
16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate |
0.017498903403062 |
0.3640163 |
NSC 728035 |
1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di |
0.017498903403062 |
0.3538958 |
NSC 730868 |
(+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one |
0.017498903403062 |
0.37805198 |